Lack of Efficacy and Safety of Eculizumab for Treatment of Antibody-Mediated Rejection Following Renal Transplantation

We evaluated the efficacy and safety of eculizumab in comparison with plasmapheresis and intravenous immunoglobulin therapy in renal transplant recipients diagnosed with antibody-mediated rejection (AMR). This was a multicenter, open-label, prospective, randomized analysis. The patients were randomi...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Transplantation proceedings 2022-10, Vol.54 (8), p.2117-2124
Hauptverfasser:	Heo, Sujung, Park, Youngchan, Lee, Nagyeom, Kim, Yanghyeon, Kim, Ye Na, Shin, Ho Sik, Jung, Yeonsoon, Rim, Hark, Rennke, Helmut G., Chandraker, Anil
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!